Your Trusted Source for Canadian News and Insights

Search keyWord:

HomeSearch

Flexport Unveils 20+ Tech and AI-Powered Products to Modernize Global Supply Chains

At the forefront of the launch are Flexport Intelligence with an AI Insights Builder, and Flexport Control Tower expanding supply chain visibility and management capabilities.

Feb 26, 2025
Hockey

China committed to acting as an 'enabler'

BEIJING,Feb. 25,2025-- A report from People\'s Daily: Recently,a foreign scholar described China as an "enabler." This term vividly encapsulates China\'s commitment to building a community w

Feb 26, 2025
Maple Syrup

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the

Feb 26, 2025
Social

G-P Expands Availability of G-P Gia™; Welcomes Leaders to the Next Era of HR

The smartest AI global HR advisor,G-P Gia,thinks like a lawyer and cuts the cost and time of compliance by up to 95%; reducing the need to outsource legal in 50 countries and 50 U.S. states

Feb 26, 2025
Social

IIIF150 Unveils Latest Flagship Raptor 5G at MWC2025

BARCELONA,Spain,Feb. 25,2025-- IIIF150,the imaginative ultra-thin rugged phone manufacture,announced their new flagship Raptor 5G which will be showcased in Barcelona,and different tests onsite to cha

Feb 26, 2025
Maple Syrup

How 51Talk is Redefining Online Education Through AI--from the Boardroom to the Classroom

SINGAPORE,Feb. 25,2025--51Talk,an online English language education platform,has announced plans to launch a comprehensive,AI-powered systems upgrade across its business operations within the coming m

Feb 26, 2025
News

CStone Announces Publication of GEMSTONE-303 Study Results for Sugemalimab (Cejemly®) in JAMA

Sugemalimab is the world\'s first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugem

Feb 26, 2025
Depth

DXC tapped by Skanska to Modernize Global IT Infrastructure

ASHBURN,VA,Feb. 25,2025-- DXC Technology,(NYSE: DXC),a leading Fortune 500 global technology services provider,has signed an agreement with Skanska AB,a multinational construction and project developm

Feb 26, 2025
Hockey

Lessons from Japan's AMR Response for the Global Community

https://iris.who.int/handle/10665/380481 TOKYO,Feb. 25,2025-- World Health Organization (WHO) Regional Office for the Western Pacific (WPRO) has released Japan\'s AMR Response 2013–2025 alongside Tok

Feb 26, 2025
Social

Baidu Acquires JOYY's Live Streaming Business in China

BEIJING,Feb. 25,2025-- Baidu,Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu"),a leading AI company with strong Internet foundation,today announced that Baid

Feb 26, 2025
News
1 ... 241 242 243 244 245 246 247 ... 461